Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 20/20 | 0.66 |
| ▸ | MTHFD1 | P11586 | 1/20 | 0.46 |
| ▸ | MTHFD2 | P13995 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21494742 | 0.82 | FPR2 (0.71) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21494610 | 0.82 | FPR2 (0.68) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21494686 | 0.79 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL30106796 | 0.79 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21494683 | 0.79 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL30106792 | 0.78 | FPR2 (0.84) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21494689 | 0.77 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL30106787 | 0.77 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21494691 | 0.77 | FPR2 (1.00) | FPR2MTHFD1MTHFD2 | |
| SCHEMBL21515028 | 0.77 | FPR2 (0.72) | FPR2MTHFD1MTHFD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781554-B1 | 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY | THOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING (SE) | 2023-06-28 | — | — | EP | disclosed |
| WO-2019201991-A1 | 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY | THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) | 2019-10-24 | — | — | WO | disclosed |